Global Bacteriophage Market Research Report- Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2035)
Description
Definition and Scope:
Bacteriophages, often referred to simply as phages, are viruses that specifically infect and lyse bacterial cells. These naturally occurring microorganisms are among the most abundant biological entities on Earth and have been explored for over a century as potential alternatives to antibiotics. Unlike broad-spectrum antibiotics, bacteriophages exhibit high specificity, targeting only designated bacterial strains without disturbing beneficial microbiota. This unique mode of action, along with their ability to evolve alongside bacterial resistance, makes them an attractive tool in combating multi-drug-resistant (MDR) bacterial infections. Bacteriophages are utilized in various applications including human and veterinary medicine, agriculture, aquaculture, and food safety. In recent years, advances in genomic engineering and synthetic biology have further expanded their therapeutic potential, including the development of phage cocktails, phage-derived enzymes, and engineered phages designed for enhanced efficacy.
In 2024, the global bacteriophage market is projected to reach approximately USD 51.36 billion, with a compound annual growth rate (CAGR) of 18.8% from 2024 to 2033. This robust growth is fueled by the escalating global threat of antimicrobial resistance (AMR), which continues to drive demand for alternative antibacterial therapies. Regulatory bodies such as the FDA and EMA have started to show increasing flexibility in approving phage-based treatments, especially in compassionate use cases and personalized medicine, which is accelerating R&D activities and commercial interest. Additionally, the food safety sector is increasingly adopting phage preparations to reduce pathogenic bacteria like Listeria, Salmonella, and E. coli without the need for chemical preservatives. At the same time, governments and biotech firms are investing in bacteriophage development platforms to bolster national antibiotic resistance strategies, while collaborations between phage therapy startups and major pharmaceutical companies are further solidifying the market’s long-term potential.
This report offers a comprehensive analysis of the global Bacteriophage market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Bacteriophage market.
Global Bacteriophage Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Bacteriophage market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Bacteriophage Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Market Segmentation by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Other
Market Segmentation by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Bacteriophage Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Bacteriophages, often referred to simply as phages, are viruses that specifically infect and lyse bacterial cells. These naturally occurring microorganisms are among the most abundant biological entities on Earth and have been explored for over a century as potential alternatives to antibiotics. Unlike broad-spectrum antibiotics, bacteriophages exhibit high specificity, targeting only designated bacterial strains without disturbing beneficial microbiota. This unique mode of action, along with their ability to evolve alongside bacterial resistance, makes them an attractive tool in combating multi-drug-resistant (MDR) bacterial infections. Bacteriophages are utilized in various applications including human and veterinary medicine, agriculture, aquaculture, and food safety. In recent years, advances in genomic engineering and synthetic biology have further expanded their therapeutic potential, including the development of phage cocktails, phage-derived enzymes, and engineered phages designed for enhanced efficacy.
In 2024, the global bacteriophage market is projected to reach approximately USD 51.36 billion, with a compound annual growth rate (CAGR) of 18.8% from 2024 to 2033. This robust growth is fueled by the escalating global threat of antimicrobial resistance (AMR), which continues to drive demand for alternative antibacterial therapies. Regulatory bodies such as the FDA and EMA have started to show increasing flexibility in approving phage-based treatments, especially in compassionate use cases and personalized medicine, which is accelerating R&D activities and commercial interest. Additionally, the food safety sector is increasingly adopting phage preparations to reduce pathogenic bacteria like Listeria, Salmonella, and E. coli without the need for chemical preservatives. At the same time, governments and biotech firms are investing in bacteriophage development platforms to bolster national antibiotic resistance strategies, while collaborations between phage therapy startups and major pharmaceutical companies are further solidifying the market’s long-term potential.
This report offers a comprehensive analysis of the global Bacteriophage market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Bacteriophage market.
Global Bacteriophage Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Bacteriophage market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Bacteriophage Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Market Segmentation by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Other
Market Segmentation by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Bacteriophage Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Table of Contents
166 Pages
- 1 Introduction
- 1.1 Bacteriophage Market Definition
- 1.2 Bacteriophage Market Segments
- 1.2.1 Segment by Type
- 1.2.2 Segment by Application
- 2 Executive Summary
- 2.1 Global Bacteriophage Market Size
- 2.2 Market Segmentation – by Type
- 2.3 Market Segmentation – by Application
- 2.4 Market Segmentation – by Geography
- 3 Key Market Trends, Opportunity, Drivers and Restraints
- 3.1 Key Takeway
- 3.2 Market Opportunities & Trends
- 3.3 Market Drivers
- 3.4 Market Restraints
- 3.5 Market Major Factor Assessment
- 4 Global Bacteriophage Market Competitive Landscape
- 4.1 Global Bacteriophage Market Share by Company (2020-2025)
- 4.2 Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 New Entrant and Capacity Expansion Plans
- 4.4 Mergers & Acquisitions
- 5 Global Bacteriophage Market by Region
- 5.1 Global Bacteriophage Market Size by Region
- 5.2 Global Bacteriophage Market Size Market Share by Region
- 6 North America Market Overview
- 6.1 North America Bacteriophage Market Size by Country
- 6.1.1 USA Market Overview
- 6.1.2 Canada Market Overview
- 6.1.3 Mexico Market Overview
- 6.2 North America Bacteriophage Market Size by Type
- 6.3 North America Bacteriophage Market Size by Application
- 6.4 Top Players in North America Bacteriophage Market
- 7 Europe Market Overview
- 7.1 Europe Bacteriophage Market Size by Country
- 7.1.1 Germany Market Overview
- 7.1.2 France Market Overview
- 7.1.3 U.K. Market Overview
- 7.1.4 Italy Market Overview
- 7.1.5 Spain Market Overview
- 7.1.6 Sweden Market Overview
- 7.1.7 Denmark Market Overview
- 7.1.8 Netherlands Market Overview
- 7.1.9 Switzerland Market Overview
- 7.1.10 Belgium Market Overview
- 7.1.11 Russia Market Overview
- 7.2 Europe Bacteriophage Market Size by Type
- 7.3 Europe Bacteriophage Market Size by Application
- 7.4 Top Players in Europe Bacteriophage Market
- 8 Asia-Pacific Market Overview
- 8.1 Asia-Pacific Bacteriophage Market Size by Country
- 8.1.1 China Market Overview
- 8.1.2 Japan Market Overview
- 8.1.3 South Korea Market Overview
- 8.1.4 India Market Overview
- 8.1.5 Australia Market Overview
- 8.1.6 Indonesia Market Overview
- 8.1.7 Malaysia Market Overview
- 8.1.8 Philippines Market Overview
- 8.1.9 Singapore Market Overview
- 8.1.10 Thailand Market Overview
- 8.2 Asia-Pacific Bacteriophage Market Size by Type
- 8.3 Asia-Pacific Bacteriophage Market Size by Application
- 8.4 Top Players in Asia-Pacific Bacteriophage Market
- 9 South America Market Overview
- 9.1 South America Bacteriophage Market Size by Country
- 9.1.1 Brazil Market Overview
- 9.1.2 Argentina Market Overview
- 9.1.3 Columbia Market Overview
- 9.2 South America Bacteriophage Market Size by Type
- 9.3 South America Bacteriophage Market Size by Application
- 9.4 Top Players in South America Bacteriophage Market
- 10 Middle East and Africa Market Overview
- 10.1 Middle East and Africa Bacteriophage Market Size by Country
- 10.1.1 Saudi Arabia Market Overview
- 10.1.2 UAE Market Overview
- 10.1.3 Egypt Market Overview
- 10.1.4 Nigeria Market Overview
- 10.1.5 South Africa Market Overview
- 10.2 Middle East and Africa Bacteriophage Market Size by Type
- 10.3 Middle East and Africa Bacteriophage Market Size by Application
- 10.4 Top Players in Middle East and Africa Bacteriophage Market
- 11 Bacteriophage Market Segmentation by Type
- 11.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 11.2 Global Bacteriophage Market Share by Type (2020-2035)
- 12 Bacteriophage Market Segmentation by Application
- 12.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 12.2 Global Bacteriophage Market Size (M USD) by Application (2020-2035)
- 12.3 Global Bacteriophage Sales Growth Rate by Application (2020-2035)
- 13 Company Profiles
- 13.1 NPO Microgen
- 13.1.1 NPO Microgen Company Overview
- 13.1.2 NPO Microgen Business Overview
- 13.1.3 NPO Microgen Bacteriophage Major Product Overview
- 13.1.4 NPO Microgen Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.1.5 Key News
- 13.2 Proteon Pharmaceuticals
- 13.2.1 Proteon Pharmaceuticals Company Overview
- 13.2.2 Proteon Pharmaceuticals Business Overview
- 13.2.3 Proteon Pharmaceuticals Bacteriophage Major Product Overview
- 13.2.4 Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.2.5 Key News
- 13.3 Phagelux
- 13.3.1 Phagelux Company Overview
- 13.3.2 Phagelux Business Overview
- 13.3.3 Phagelux Bacteriophage Major Product Overview
- 13.3.4 Phagelux Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.3.5 Key News
- 13.4 Intralytix
- 13.4.1 Intralytix Company Overview
- 13.4.2 Intralytix Business Overview
- 13.4.3 Intralytix Bacteriophage Major Product Overview
- 13.4.4 Intralytix Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.4.5 Key News
- 13.5 Micreos
- 13.5.1 Micreos Company Overview
- 13.5.2 Micreos Business Overview
- 13.5.3 Micreos Bacteriophage Major Product Overview
- 13.5.4 Micreos Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.5.5 Key News
- 13.6 Eliava BioPreparations
- 13.6.1 Eliava BioPreparations Company Overview
- 13.6.2 Eliava BioPreparations Business Overview
- 13.6.3 Eliava BioPreparations Bacteriophage Major Product Overview
- 13.6.4 Eliava BioPreparations Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.6.5 Key News
- 13.7 Locus Biosciences,Inc
- 13.7.1 Locus Biosciences,Inc Company Overview
- 13.7.2 Locus Biosciences,Inc Business Overview
- 13.7.3 Locus Biosciences,Inc Bacteriophage Major Product Overview
- 13.7.4 Locus Biosciences,Inc Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.7.5 Key News
- 13.8 Pharmex Group,LLC
- 13.8.1 Pharmex Group,LLC Company Overview
- 13.8.2 Pharmex Group,LLC Business Overview
- 13.8.3 Pharmex Group,LLC Bacteriophage Major Product Overview
- 13.8.4 Pharmex Group,LLC Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.8.5 Key News
- 13.9 Pherecydes Pharma
- 13.9.1 Pherecydes Pharma Company Overview
- 13.9.2 Pherecydes Pharma Business Overview
- 13.9.3 Pherecydes Pharma Bacteriophage Major Product Overview
- 13.9.4 Pherecydes Pharma Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.9.5 Key News
- 13.10 APS Biocontrol Ltd. (APS)
- 13.10.1 APS Biocontrol Ltd. (APS) Company Overview
- 13.10.2 APS Biocontrol Ltd. (APS) Business Overview
- 13.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Major Product Overview
- 13.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.10.5 Key News
- 13.11 Qingdao Phagepharm Bio-tech
- 13.11.1 Qingdao Phagepharm Bio-tech Company Overview
- 13.11.2 Qingdao Phagepharm Bio-tech Business Overview
- 13.11.3 Qingdao Phagepharm Bio-tech Bacteriophage Major Product Overview
- 13.11.4 Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.11.5 Key News
- 13.12 Fixed-Phage Limited
- 13.12.1 Fixed-Phage Limited Company Overview
- 13.12.2 Fixed-Phage Limited Business Overview
- 13.12.3 Fixed-Phage Limited Bacteriophage Major Product Overview
- 13.12.4 Fixed-Phage Limited Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.12.5 Key News
- 13.13 Zeptometrix
- 13.13.1 Zeptometrix Company Overview
- 13.13.2 Zeptometrix Business Overview
- 13.13.3 Zeptometrix Bacteriophage Major Product Overview
- 13.13.4 Zeptometrix Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.13.5 Key News
- 13.14 Phage International, Inc.
- 13.14.1 Phage International, Inc. Company Overview
- 13.14.2 Phage International, Inc. Business Overview
- 13.14.3 Phage International, Inc. Bacteriophage Major Product Overview
- 13.14.4 Phage International, Inc. Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.14.5 Key News
- 13.15 MicroMir
- 13.15.1 MicroMir Company Overview
- 13.15.2 MicroMir Business Overview
- 13.15.3 MicroMir Bacteriophage Major Product Overview
- 13.15.4 MicroMir Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.15.5 Key News
- 13.16 iNtODEWORLD, Inc.
- 13.16.1 iNtODEWORLD, Inc. Company Overview
- 13.16.2 iNtODEWORLD, Inc. Business Overview
- 13.16.3 iNtODEWORLD, Inc. Bacteriophage Major Product Overview
- 13.16.4 iNtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.16.5 Key News
- 13.17 NEXTBIOTICS
- 13.17.1 NEXTBIOTICS Company Overview
- 13.17.2 NEXTBIOTICS Business Overview
- 13.17.3 NEXTBIOTICS Bacteriophage Major Product Overview
- 13.17.4 NEXTBIOTICS Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.17.5 Key News
- 13.18 Armata Pharmaceuticals, Inc.
- 13.18.1 Armata Pharmaceuticals, Inc. Company Overview
- 13.18.2 Armata Pharmaceuticals, Inc. Business Overview
- 13.18.3 Armata Pharmaceuticals, Inc. Bacteriophage Major Product Overview
- 13.18.4 Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.18.5 Key News
- 13.19 Innophage
- 13.19.1 Innophage Company Overview
- 13.19.2 Innophage Business Overview
- 13.19.3 Innophage Bacteriophage Major Product Overview
- 13.19.4 Innophage Bacteriophage Revenue and Gross Margin fromBacteriophage (2020-2025)
- 13.19.5 Key News
- 14 Key Market Trends, Opportunity, Drivers and Restraints
- 14.1 Key Takeway
- 14.2 Market Opportunities & Trends
- 14.3 Market Drivers
- 14.4 Market Restraints
- 14.5 Market Major Factor Assessment
- 14.6 Porter's Five Forces Analysis of Bacteriophage Market
- 14.7 PEST Analysis of Bacteriophage Market
- 15 Analysis of the Bacteriophage Industry Chain
- 15.1 Overview of the Industry Chain
- 15.2 Upstream Segment Analysis
- 15.3 Midstream Segment Analysis
- 15.3.1 Manufacturing, Processing or Conversion Process Analysis
- 15.3.2 Key Technology Analysis
- 15.4 Downstream Segment Analysis
- 15.4.1 Downstream Customer List and Contact Details
- 15.4.2 Customer Concerns or Preference Analysis
- 16 Conclusion
- 17 Appendix
- 17.1 Methodology
- 17.2 Research Process and Data Source
- 17.3 Disclaimer
- 17.4 Note
- 17.5 Examples of Clients
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
